PD-1 Inhibitor Market - Global Outlook and Forecast 2023-2028

Report ID: 1369881 | Published Date: Jan 2025 | No. of Page: 66 | Base Year: 2024 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 PD-1 Inhibitor Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global PD-1 Inhibitor Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global PD-1 Inhibitor Overall Market Size
    2.1 Global PD-1 Inhibitor Market Size: 2021 VS 2028
    2.2 Global PD-1 Inhibitor Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top PD-1 Inhibitor Players in Global Market
    3.2 Top Global PD-1 Inhibitor Companies Ranked by Revenue
    3.3 Global PD-1 Inhibitor Revenue by Companies
    3.4 Top 3 and Top 5 PD-1 Inhibitor Companies in Global Market, by Revenue in 2021
    3.5 Global Companies PD-1 Inhibitor Product Type
    3.6 Tier 1, Tier 2 and Tier 3 PD-1 Inhibitor Players in Global Market
        3.6.1 List of Global Tier 1 PD-1 Inhibitor Companies
        3.6.2 List of Global Tier 2 and Tier 3 PD-1 Inhibitor Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global PD-1 Inhibitor Market Size Markets, 2021 & 2028
        4.1.2 Pembrolizumab
        4.1.3 Nivolumab
        4.1.4 Atezolizumab
        4.1.5 Durvalumab
        4.1.6 Avelumab
        4.1.7 Other
    4.2 By Type - Global PD-1 Inhibitor Revenue & Forecasts
        4.2.1 By Type - Global PD-1 Inhibitor Revenue, 2017-2022
        4.2.2 By Type - Global PD-1 Inhibitor Revenue, 2023-2028
        4.2.3 By Type - Global PD-1 Inhibitor Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global PD-1 Inhibitor Market Size, 2021 & 2028
        5.1.2 Melanoma
        5.1.3 Non-small Cell Lung Cancer (NSCLC)
        5.1.4 Urothelial Carcinoma
        5.1.5 Classical Hodgkin Lymphoma
        5.1.6 Renal Cell Carcinoma
        5.1.7 Other
    5.2 By Application - Global PD-1 Inhibitor Revenue & Forecasts
        5.2.1 By Application - Global PD-1 Inhibitor Revenue, 2017-2022
        5.2.2 By Application - Global PD-1 Inhibitor Revenue, 2023-2028
        5.2.3 By Application - Global PD-1 Inhibitor Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global PD-1 Inhibitor Market Size, 2021 & 2028
    6.2 By Region - Global PD-1 Inhibitor Revenue & Forecasts
        6.2.1 By Region - Global PD-1 Inhibitor Revenue, 2017-2022
        6.2.2 By Region - Global PD-1 Inhibitor Revenue, 2023-2028
        6.2.3 By Region - Global PD-1 Inhibitor Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America PD-1 Inhibitor Revenue, 2017-2028
        6.3.2 US PD-1 Inhibitor Market Size, 2017-2028
        6.3.3 Canada PD-1 Inhibitor Market Size, 2017-2028
        6.3.4 Mexico PD-1 Inhibitor Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe PD-1 Inhibitor Revenue, 2017-2028
        6.4.2 Germany PD-1 Inhibitor Market Size, 2017-2028
        6.4.3 France PD-1 Inhibitor Market Size, 2017-2028
        6.4.4 U.K. PD-1 Inhibitor Market Size, 2017-2028
        6.4.5 Italy PD-1 Inhibitor Market Size, 2017-2028
        6.4.6 Russia PD-1 Inhibitor Market Size, 2017-2028
        6.4.7 Nordic Countries PD-1 Inhibitor Market Size, 2017-2028
        6.4.8 Benelux PD-1 Inhibitor Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia PD-1 Inhibitor Revenue, 2017-2028
        6.5.2 China PD-1 Inhibitor Market Size, 2017-2028
        6.5.3 Japan PD-1 Inhibitor Market Size, 2017-2028
        6.5.4 South Korea PD-1 Inhibitor Market Size, 2017-2028
        6.5.5 Southeast Asia PD-1 Inhibitor Market Size, 2017-2028
        6.5.6 India PD-1 Inhibitor Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America PD-1 Inhibitor Revenue, 2017-2028
        6.6.2 Brazil PD-1 Inhibitor Market Size, 2017-2028
        6.6.3 Argentina PD-1 Inhibitor Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa PD-1 Inhibitor Revenue, 2017-2028
        6.7.2 Turkey PD-1 Inhibitor Market Size, 2017-2028
        6.7.3 Israel PD-1 Inhibitor Market Size, 2017-2028
        6.7.4 Saudi Arabia PD-1 Inhibitor Market Size, 2017-2028
        6.7.5 UAE PD-1 Inhibitor Market Size, 2017-2028
7 Players Profiles
    7.1 Merck
        7.1.1 Merck Corporate Summary
        7.1.2 Merck Business Overview
        7.1.3 Merck PD-1 Inhibitor Major Product Offerings
        7.1.4 Merck PD-1 Inhibitor Revenue in Global Market (2017-2022)
        7.1.5 Merck Key News
    7.2 Novartis
        7.2.1 Novartis Corporate Summary
        7.2.2 Novartis Business Overview
        7.2.3 Novartis PD-1 Inhibitor Major Product Offerings
        7.2.4 Novartis PD-1 Inhibitor Revenue in Global Market (2017-2022)
        7.2.5 Novartis Key News
    7.3 Onxeo
        7.3.1 Onxeo Corporate Summary
        7.3.2 Onxeo Business Overview
        7.3.3 Onxeo PD-1 Inhibitor Major Product Offerings
        7.3.4 Onxeo PD-1 Inhibitor Revenue in Global Market (2017-2022)
        7.3.5 Onxeo Key News
    7.4 Sumitomo Dainippon Pharma
        7.4.1 Sumitomo Dainippon Pharma Corporate Summary
        7.4.2 Sumitomo Dainippon Pharma Business Overview
        7.4.3 Sumitomo Dainippon Pharma PD-1 Inhibitor Major Product Offerings
        7.4.4 Sumitomo Dainippon Pharma PD-1 Inhibitor Revenue in Global Market (2017-2022)
        7.4.5 Sumitomo Dainippon Pharma Key News
    7.5 Taiwan Liposome Company
        7.5.1 Taiwan Liposome Company Corporate Summary
        7.5.2 Taiwan Liposome Company Business Overview
        7.5.3 Taiwan Liposome Company PD-1 Inhibitor Major Product Offerings
        7.5.4 Taiwan Liposome Company PD-1 Inhibitor Revenue in Global Market (2017-2022)
        7.5.5 Taiwan Liposome Company Key News
    7.6 Tiziana Life Sciences
        7.6.1 Tiziana Life Sciences Corporate Summary
        7.6.2 Tiziana Life Sciences Business Overview
        7.6.3 Tiziana Life Sciences PD-1 Inhibitor Major Product Offerings
        7.6.4 Tiziana Life Sciences PD-1 Inhibitor Revenue in Global Market (2017-2022)
        7.6.5 Tiziana Life Sciences Key News
    7.7 Genentech (Roche)
        7.7.1 Genentech (Roche) Corporate Summary
        7.7.2 Genentech (Roche) Business Overview
        7.7.3 Genentech (Roche) PD-1 Inhibitor Major Product Offerings
        7.7.4 Genentech (Roche) PD-1 Inhibitor Revenue in Global Market (2017-2022)
        7.7.5 Genentech (Roche) Key News
    7.8 AstraZeneca
        7.8.1 AstraZeneca Corporate Summary
        7.8.2 AstraZeneca Business Overview
        7.8.3 AstraZeneca PD-1 Inhibitor Major Product Offerings
        7.8.4 AstraZeneca PD-1 Inhibitor Revenue in Global Market (2017-2022)
        7.8.5 AstraZeneca Key News
    7.9 Pfizer
        7.9.1 Pfizer Corporate Summary
        7.9.2 Pfizer Business Overview
        7.9.3 Pfizer PD-1 Inhibitor Major Product Offerings
        7.9.4 Pfizer PD-1 Inhibitor Revenue in Global Market (2017-2022)
        7.9.5 Pfizer Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. PD-1 Inhibitor Market Opportunities & Trends in Global Market
    Table 2. PD-1 Inhibitor Market Drivers in Global Market
    Table 3. PD-1 Inhibitor Market Restraints in Global Market
    Table 4. Key Players of PD-1 Inhibitor in Global Market
    Table 5. Top PD-1 Inhibitor Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global PD-1 Inhibitor Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global PD-1 Inhibitor Revenue Share by Companies, 2017-2022
    Table 8. Global Companies PD-1 Inhibitor Product Type
    Table 9. List of Global Tier 1 PD-1 Inhibitor Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 PD-1 Inhibitor Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global PD-1 Inhibitor Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - PD-1 Inhibitor Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - PD-1 Inhibitor Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global PD-1 Inhibitor Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - PD-1 Inhibitor Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - PD-1 Inhibitor Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global PD-1 Inhibitor Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global PD-1 Inhibitor Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global PD-1 Inhibitor Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America PD-1 Inhibitor Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America PD-1 Inhibitor Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe PD-1 Inhibitor Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe PD-1 Inhibitor Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia PD-1 Inhibitor Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia PD-1 Inhibitor Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America PD-1 Inhibitor Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America PD-1 Inhibitor Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa PD-1 Inhibitor Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa PD-1 Inhibitor Revenue, (US$, Mn), 2023-2028
    Table 30. Merck Corporate Summary
    Table 31. Merck PD-1 Inhibitor Product Offerings
    Table 32. Merck PD-1 Inhibitor Revenue (US$, Mn), (2017-2022)
    Table 33. Novartis Corporate Summary
    Table 34. Novartis PD-1 Inhibitor Product Offerings
    Table 35. Novartis PD-1 Inhibitor Revenue (US$, Mn), (2017-2022)
    Table 36. Onxeo Corporate Summary
    Table 37. Onxeo PD-1 Inhibitor Product Offerings
    Table 38. Onxeo PD-1 Inhibitor Revenue (US$, Mn), (2017-2022)
    Table 39. Sumitomo Dainippon Pharma Corporate Summary
    Table 40. Sumitomo Dainippon Pharma PD-1 Inhibitor Product Offerings
    Table 41. Sumitomo Dainippon Pharma PD-1 Inhibitor Revenue (US$, Mn), (2017-2022)
    Table 42. Taiwan Liposome Company Corporate Summary
    Table 43. Taiwan Liposome Company PD-1 Inhibitor Product Offerings
    Table 44. Taiwan Liposome Company PD-1 Inhibitor Revenue (US$, Mn), (2017-2022)
    Table 45. Tiziana Life Sciences Corporate Summary
    Table 46. Tiziana Life Sciences PD-1 Inhibitor Product Offerings
    Table 47. Tiziana Life Sciences PD-1 Inhibitor Revenue (US$, Mn), (2017-2022)
    Table 48. Genentech (Roche) Corporate Summary
    Table 49. Genentech (Roche) PD-1 Inhibitor Product Offerings
    Table 50. Genentech (Roche) PD-1 Inhibitor Revenue (US$, Mn), (2017-2022)
    Table 51. AstraZeneca Corporate Summary
    Table 52. AstraZeneca PD-1 Inhibitor Product Offerings
    Table 53. AstraZeneca PD-1 Inhibitor Revenue (US$, Mn), (2017-2022)
    Table 54. Pfizer Corporate Summary
    Table 55. Pfizer PD-1 Inhibitor Product Offerings
    Table 56. Pfizer PD-1 Inhibitor Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. PD-1 Inhibitor Segment by Type in 2021
    Figure 2. PD-1 Inhibitor Segment by Application in 2021
    Figure 3. Global PD-1 Inhibitor Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global PD-1 Inhibitor Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global PD-1 Inhibitor Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by PD-1 Inhibitor Revenue in 2021
    Figure 8. By Type - Global PD-1 Inhibitor Revenue Market Share, 2017-2028
    Figure 9. By Application - Global PD-1 Inhibitor Revenue Market Share, 2017-2028
    Figure 10. By Region - Global PD-1 Inhibitor Revenue Market Share, 2017-2028
    Figure 11. By Country - North America PD-1 Inhibitor Revenue Market Share, 2017-2028
    Figure 12. US PD-1 Inhibitor Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada PD-1 Inhibitor Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico PD-1 Inhibitor Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe PD-1 Inhibitor Revenue Market Share, 2017-2028
    Figure 16. Germany PD-1 Inhibitor Revenue, (US$, Mn), 2017-2028
    Figure 17. France PD-1 Inhibitor Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. PD-1 Inhibitor Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy PD-1 Inhibitor Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia PD-1 Inhibitor Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries PD-1 Inhibitor Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux PD-1 Inhibitor Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia PD-1 Inhibitor Revenue Market Share, 2017-2028
    Figure 24. China PD-1 Inhibitor Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan PD-1 Inhibitor Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea PD-1 Inhibitor Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia PD-1 Inhibitor Revenue, (US$, Mn), 2017-2028
    Figure 28. India PD-1 Inhibitor Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America PD-1 Inhibitor Revenue Market Share, 2017-2028
    Figure 30. Brazil PD-1 Inhibitor Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina PD-1 Inhibitor Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa PD-1 Inhibitor Revenue Market Share, 2017-2028
    Figure 33. Turkey PD-1 Inhibitor Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel PD-1 Inhibitor Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia PD-1 Inhibitor Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE PD-1 Inhibitor Revenue, (US$, Mn), 2017-2028
    Figure 37. Merck PD-1 Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Novartis PD-1 Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Onxeo PD-1 Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Sumitomo Dainippon Pharma PD-1 Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Taiwan Liposome Company PD-1 Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Tiziana Life Sciences PD-1 Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Genentech (Roche) PD-1 Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. AstraZeneca PD-1 Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Pfizer PD-1 Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
66
Frequently Asked Questions
PD-1 Inhibitor Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
PD-1 Inhibitor Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
PD-1 Inhibitor Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Nivolumab Market

This report contains market size and forecasts of Nivolumab in global, including the following ma ... Read More

Durvalumab Market

This report contains market size and forecasts of Durvalumab in global, including the following m ... Read More

Pembrolizumab Market

This report contains market size and forecasts of Pembrolizumab in global, including the followin ... Read More

Atezolizumab Market

This report contains market size and forecasts of Atezolizumab in global, including the following ... Read More